Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Mayo Clinic Identifier:
First received: November 1, 1999
Last updated: May 10, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: August 2002 (Final data collection date for primary outcome measure)